PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy.
Valerio ForteA U CavalloRiccardo BertoloV de SoccioM SperandioP BoveM CiccarielloPublished in: Prostate cancer and prostatic diseases (2020)
In our experience the PI-RADS score proved to be sufficiently accurate in predicting prostate cancer in patients under dutasteride therapy.